In the position statement, a multidisciplinary group of experts provide a state-of-the art update addressing evidence regarding PCI in patients with complex clinical and anatomical features and provide procedural guidance to achieve optimal outcomes for this challenging patient group. The document examines pre-procedural assessment of coronary anatomical complexity and higher-risk clinical features and interventional treatment of complex coronary artery disease.
Robert F Riley (The Christ Hospital, Cincinnati, USA), member of the document writing group, says: “Over the last several years, there has been an increase in the anatomic and physiologic complexity of patients presenting to the catheterisation lab. During that time, a multitude of tools have been developed to aid defining and treating this group when percutaneous revascularisation is indicated. However, this population has been incompletely defined up to this point and there is a need to provide a contemporary evidence-based document that specifically addresses aspects of complex PCI in this patient group.”
He adds: “This document further complements the concomitantly published SCAI statement on the performance of PCI in ambulatory surgical centres. Together, we hope these documents will provide guidance on best practices and the performance settings for PCI across the spectrum of clinical and anatomical complexity.”
SCAI is holding its annual meeting online between 14 and 16 May, Eastern Time.
Duc Tin Clinic
Performance diagnostique de l’interféron gamma dans l’identification de l’origine tuberculeuse des pleurésies exsudatives
A Mixed Phenotype of Airway Wall Thickening and Emphysema Is Associated with Dyspnea and Hospitalization for Chronic Obstructive Pulmonary Disease.
Radiological Approach to Asthma and COPD-The Role of Computed Tomography.
Significant annual cost savings found with UrgoStart in UK and Germany
Thrombolex announces 510(k) clearance of Bashir catheter systems for thromboembolic disorders
Phone: (028) 3981 2678
Mobile: 0903 839 878 - 0909 384 389